DB12766InvestigationalSmall molecule
Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial Hypertension.
- Mechanism
- Curator reviewed
Pharmacologically active on cGMP-specific 3',5'-cyclic phosphodiesterase, Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A, and Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Formula / weight
- C14H12ClNO2 · 261.71 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
CVKNDPRBJVBDSS-UHFFFAOYSA-NSMILESCC1=C(O)C2=C(C=N1)C(OC2)C1=CC=C(Cl)C=C1What you can answer from here — as of September 12, 2026
5Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Cicletanine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account